G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69 | -21.6% | 25,820 | +58.5% | 0.01% | -33.3% |
| Q4 2022 | $88 | -100.0% | 16,291 | +9.3% | 0.01% | -50.0% |
| Q3 2022 | $186,000 | +1.1% | 14,901 | -38.4% | 0.02% | -18.2% |
| Q1 2022 | $184,000 | -23.3% | 24,187 | +81.6% | 0.02% | -43.6% |
| Q4 2020 | $240,000 | +3.4% | 13,319 | -33.7% | 0.04% | +5.4% |
| Q3 2020 | $232,000 | +5.9% | 20,085 | +122.9% | 0.04% | +12.1% |
| Q2 2020 | $219,000 | -2.2% | 9,010 | -33.2% | 0.03% | -10.8% |
| Q1 2019 | $224,000 | -18.2% | 13,488 | +157.9% | 0.04% | -2.6% |
| Q3 2018 | $274,000 | – | 5,230 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |